Incorrect Access Control Vulnerability in Zkteco BioTime Software
CVE-2022-38802

6.2MEDIUM

Key Information:

Vendor

Zkteco

Status
Biotime
Vendor
CVE Published:
30 November 2022

What is CVE-2022-38802?

Zkteco BioTime prior to version 8.5.3 Build:20200816.447 has an incorrect access control vulnerability that allows authenticated administrators to exploit cross-site scripting (XSS) during data export. This security flaw enables the unauthorized access and reading of local files through various sensitive functionalities including resign, private message handling, manual logs, time intervals, attendance shifts, and holidays. Organizations utilizing affected versions should take prompt action to safeguard their systems.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

References

https://www.zkteco.com/
https://gist.github.com/hamoshwani/fd7e3d9d9ff8896f1ccf84...

CVSS V3.1

Score:
6.2
Severity:
MEDIUM
Confidentiality:
High
Integrity:
None
Availability:
High
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
High
User Interaction:
Required
Scope:
Changed

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.